Innealta Capital’s Aspen Aerogels ASPN Stock Holding History

Innealta Capital’s Portfolio ASPN Stock Details ASPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-23	Closed	-$549	–	270
2024 Q2	$549	Buy	+23	New	+$540	﹤0.01%	1457

Other funds holding ASPN

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

GKFF

George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

ECA

Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Innealta Capital's ASPN Position: Q3 2024 in Review

Innealta Capital sold out of Aspen Aerogels (ASPN) in Q3 2024, closing a stake of 23 shares — an estimated $549 sold.

Innealta Capital first reported a position in ASPN in Q2 2024 and held it in 1 quarter. The position peaked at $549 in Q2 2024. 243 funds tracked by Wall St. Rank hold ASPN as of Q3 2024.

Innealta Capital reported no remaining Aspen Aerogels position as of Q3 2024 after selling out during the quarter.
Innealta Capital sold 23 Aspen Aerogels shares in Q3 2024, an estimated $549.
Innealta Capital first reported a position in Aspen Aerogels in Q2 2024 and held it in 1 quarter.
Innealta Capital's Aspen Aerogels position peaked at $549 in Q2 2024.
243 funds tracked by Wall St. Rank held Aspen Aerogels as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.